Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes.

Boudreau DM, Yu O, Gray SL, Raebel MA, Johnson J, Larson EB.

J Am Geriatr Soc. 2011 Nov;59(11):2069-76. doi: 10.1111/j.1532-5415.2011.03654.x. Epub 2011 Oct 22.

PMID:
22091958
[PubMed - indexed for MEDLINE]
2.

Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes.

Modi A, Weiner M, Craig BA, Sands LP, Rosenman MB, Thomas J 3rd.

J Am Geriatr Soc. 2009 Jul;57(7):1238-44. doi: 10.1111/j.1532-5415.2009.02258.x. Epub 2009 Apr 17.

PMID:
19467148
[PubMed - indexed for MEDLINE]
3.

Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Sink KM, Thomas J 3rd, Xu H, Craig B, Kritchevsky S, Sands LP.

J Am Geriatr Soc. 2008 May;56(5):847-53. doi: 10.1111/j.1532-5415.2008.01681.x. Epub 2008 Apr 1.

PMID:
18384584
[PubMed - indexed for MEDLINE]
4.

Use of anticholinergic medications by older adults with dementia.

Roe CM, Anderson MJ, Spivack B.

J Am Geriatr Soc. 2002 May;50(5):836-42.

PMID:
12028169
[PubMed - indexed for MEDLINE]
5.
6.

The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?

Carnahan RM, Lund BC, Perry PJ, Chrischilles EA.

J Am Geriatr Soc. 2004 Dec;52(12):2082-7.

PMID:
15571547
[PubMed - indexed for MEDLINE]
7.

Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.

Mucha L, Shaohung S, Cuffel B, McRae T, Mark TL, Del Valle M.

J Manag Care Pharm. 2008 Jun;14(5):451-61.

PMID:
18597574
[PubMed - indexed for MEDLINE]
Free Article
8.

Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.

Daiello LA, Ott BR, Lapane KL, Reinert SE, Machan JT, Dore DD.

Am J Geriatr Pharmacother. 2009 Apr;7(2):74-83. doi: 10.1016/j.amjopharm.2009.04.002.

PMID:
19447360
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
10.

Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition.

Kogut SJ, El-Maouche D, Abughosh SM.

Pharmacotherapy. 2005 Dec;25(12):1729-35.

PMID:
16305292
[PubMed - indexed for MEDLINE]
11.

Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.

Dybicz SB, Keohane DJ, Erwin WG, McRae T, Shah SN.

Am J Geriatr Pharmacother. 2006 Jun;4(2):154-60.

PMID:
16860262
[PubMed - indexed for MEDLINE]
12.

A population-based study of cholinesterase inhibitor use for dementia.

Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA.

J Am Geriatr Soc. 2007 Oct;55(10):1517-23. Epub 2007 Aug 14.

PMID:
17697100
[PubMed - indexed for MEDLINE]
13.

Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients.

Johnell K, Fastbom J.

Drugs Aging. 2008;25(10):871-7.

PMID:
18808211
[PubMed - indexed for MEDLINE]
14.

A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.

Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J.

Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv. doi: 10.3310/hta15280.

PMID:
21810375
[PubMed - indexed for MEDLINE]
Free Article
15.

Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.

Wang PS, Levin R, Zhao SZ, Avorn J.

J Am Geriatr Soc. 2002 Jan;50(1):117-24.

PMID:
12028256
[PubMed - indexed for MEDLINE]
16.

Inappropriate prescribing before and after nursing home admission.

Dhalla IA, Anderson GM, Mamdani MM, Bronskill SE, Sykora K, Rochon PA.

J Am Geriatr Soc. 2002 Jun;50(6):995-1000.

PMID:
12110057
[PubMed - indexed for MEDLINE]
17.

A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.

Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA.

Arch Intern Med. 2005 Apr 11;165(7):808-13.

PMID:
15824303
[PubMed - indexed for MEDLINE]
18.

Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes.

Eaton CB, Lapane KL, Murphy JB, Hume AL.

J Am Geriatr Soc. 2002 Aug;50(8):1389-95.

PMID:
12164995
[PubMed - indexed for MEDLINE]
19.

Prevalence of mental illness and its impact on the use of home care and nursing homes: a population-based study of older adults in Manitoba.

Martens PJ, Fransoo R, Burland E, Burchill C, Prior HJ, Ekuma O; Need to Know Team.

Can J Psychiatry. 2007 Sep;52(9):581-90.

PMID:
17953162
[PubMed - indexed for MEDLINE]
20.

Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.

Chatterjee S, Mehta S, Sherer JT, Aparasu RR.

Drugs Aging. 2010 Dec 1;27(12):987-97. doi: 10.2165/11584430-000000000-00000.

PMID:
21087068
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk